QIAGEN and EQT Private Equity announce agreement on a recommended voluntary all-cash public takeover offer

Impact · against what's priced in

QIAGEN's price will likely gap up to the offer price of €46.50 per share. This takeover agreement provides a definitive exit value that exceeds previous expectations based on organic growth and strategic reviews.

QGEN+0.70

Not in the price yet

The price assumes

ongoing strategic review

The all-cash offer of €46.50 per share resolves the strategic review mentioned in the market's current valuation with a concrete acquisition premium, bypassing the uncertainty of the organic growth drivers the market was previously tracking.